← FDA Drug Approvals (Drugs@FDA)

AKOVAZ

NDA · New Drug Application · Sponsor: EXELA PHARMA · Approved 2016-04-29

Drug application

FDA Application #

NDA208289

Application type

New Drug Application

Brand name

AKOVAZ

Generic name

EPHEDRINE SULFATE

Active ingredients

EPHEDRINE SULFATE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

EXELA PHARMA

Manufacturer

Exela Pharma Sciences, LLC

First approval

2016-04-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown